OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
Konstantinos Papamichael, Waqqas Afif, David Drobne, et al.
The Lancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 2, pp. 171-185
Open Access | Times Cited: 109
Konstantinos Papamichael, Waqqas Afif, David Drobne, et al.
The Lancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 2, pp. 171-185
Open Access | Times Cited: 109
Showing 1-25 of 109 citing articles:
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives
Peter M. Irving, K Gecse
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1512-1524
Open Access | Times Cited: 73
Peter M. Irving, K Gecse
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1512-1524
Open Access | Times Cited: 73
ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
Hannah Gordon, Silvia Minozzi, Uri Kopylov, et al.
Journal of Crohn s and Colitis (2024)
Open Access | Times Cited: 49
Hannah Gordon, Silvia Minozzi, Uri Kopylov, et al.
Journal of Crohn s and Colitis (2024)
Open Access | Times Cited: 49
The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease
Sem Geertsema, Arno R. Bourgonje, Raphael R. Fagundes, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 10, pp. 830-842
Open Access | Times Cited: 44
Sem Geertsema, Arno R. Bourgonje, Raphael R. Fagundes, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 10, pp. 830-842
Open Access | Times Cited: 44
Review article: the future of microbiome‐based therapeutics
Emily L. Gulliver, Remy B. Young, Michelle Chonwerawong, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 2, pp. 192-208
Open Access | Times Cited: 61
Emily L. Gulliver, Remy B. Young, Michelle Chonwerawong, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 2, pp. 192-208
Open Access | Times Cited: 61
MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT
Jie Zhang, Li Cen, Xiaofen Zhang, et al.
Redox Biology (2022) Vol. 56, pp. 102469-102469
Open Access | Times Cited: 60
Jie Zhang, Li Cen, Xiaofen Zhang, et al.
Redox Biology (2022) Vol. 56, pp. 102469-102469
Open Access | Times Cited: 60
Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Nghia Nguyen, Virginia Solitano, Sudheer K. Vuyyuru, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 937-949.e2
Open Access | Times Cited: 45
Nghia Nguyen, Virginia Solitano, Sudheer K. Vuyyuru, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 937-949.e2
Open Access | Times Cited: 45
Inflammatory bowel disease: recent developments
James J. Ashton, R. Mark Beattie
Archives of Disease in Childhood (2023) Vol. 109, Iss. 5, pp. 370-376
Open Access | Times Cited: 25
James J. Ashton, R. Mark Beattie
Archives of Disease in Childhood (2023) Vol. 109, Iss. 5, pp. 370-376
Open Access | Times Cited: 25
FUT2-dependent fucosylation of HYOU1 protects intestinal stem cells against inflammatory injury by regulating unfolded protein response
Zhe Wang, Chen Tan, Caihan Duan, et al.
Redox Biology (2023) Vol. 60, pp. 102618-102618
Open Access | Times Cited: 21
Zhe Wang, Chen Tan, Caihan Duan, et al.
Redox Biology (2023) Vol. 60, pp. 102618-102618
Open Access | Times Cited: 21
Model-informed precision dosing: State of the art and future perspectives
Iris K. Minichmayr, Erwin Dreesen, Marco Centanni, et al.
Advanced Drug Delivery Reviews (2024) Vol. 215, pp. 115421-115421
Open Access | Times Cited: 10
Iris K. Minichmayr, Erwin Dreesen, Marco Centanni, et al.
Advanced Drug Delivery Reviews (2024) Vol. 215, pp. 115421-115421
Open Access | Times Cited: 10
Targeted delivery of Fc-fused PD-L1 for effective management of acute and chronic colitis
Xu-Dong Tang, Yangyang Shang, Hong Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Xu-Dong Tang, Yangyang Shang, Hong Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease
Thanaboon Chaemsupaphan, Rupert W. Leong, Niels Vande Casteele, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1234-1243
Open Access | Times Cited: 8
Thanaboon Chaemsupaphan, Rupert W. Leong, Niels Vande Casteele, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1234-1243
Open Access | Times Cited: 8
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review
Javier Plaza Zamora, Alejandro Mínguez, Guillermo Bastida, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3717-3717
Open Access | Times Cited: 6
Javier Plaza Zamora, Alejandro Mínguez, Guillermo Bastida, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3717-3717
Open Access | Times Cited: 6
Intestinal tissue levels of anti-TNF alpha, antibodies, and cytokines in paediatric Crohn disease
Vojtěch Dotlačil, Štěpán Coufal, Tereza Lerchová, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Vojtěch Dotlačil, Štěpán Coufal, Tereza Lerchová, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Discovery of 7-Azaindole Inhibitors of Inflammasomes/Il-1β for the Treatment of Inflammatory Bowel Disease
Yuyun Yan, Xiuxiu Zhang, Ruiwen Wu, et al.
(2025)
Closed Access
Yuyun Yan, Xiuxiu Zhang, Ruiwen Wu, et al.
(2025)
Closed Access
Curcumin attenuates ulcerative colitis via regulation of Sphingosine kinases 1 /NF ‐κB signaling pathway
Xiuli Zhang, Hao Zhang, Jingting Wang, et al.
BioFactors (2025) Vol. 51, Iss. 1
Closed Access
Xiuli Zhang, Hao Zhang, Jingting Wang, et al.
BioFactors (2025) Vol. 51, Iss. 1
Closed Access
Comprehensive care of ulcerative colitis: new treatment strategies
Thanaboon Chaemsupaphan, Arteen Arzivian, Rupert W. Leong
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Thanaboon Chaemsupaphan, Arteen Arzivian, Rupert W. Leong
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study
Sailish Honap, Bénédicte Caron, Jacob E. Ollech, et al.
Digestive Diseases and Sciences (2025)
Closed Access
Sailish Honap, Bénédicte Caron, Jacob E. Ollech, et al.
Digestive Diseases and Sciences (2025)
Closed Access
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine
Matthew B. Stanton, Mark Solinski, Stephen B. Hanauer
Expert Review of Clinical Immunology (2025), pp. 1-12
Closed Access
Matthew B. Stanton, Mark Solinski, Stephen B. Hanauer
Expert Review of Clinical Immunology (2025), pp. 1-12
Closed Access
Overcoming the challenges of overtreating and undertreating inflammatory bowel disease
María José Temido, Sailish Honap, Vipul Jairath, et al.
The Lancet. Gastroenterology & hepatology (2025)
Closed Access
María José Temido, Sailish Honap, Vipul Jairath, et al.
The Lancet. Gastroenterology & hepatology (2025)
Closed Access
National perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease
Brad D. Constant, Jeremy Adler, Benjamin D. Gold, et al.
JPGN Reports (2025)
Open Access
Brad D. Constant, Jeremy Adler, Benjamin D. Gold, et al.
JPGN Reports (2025)
Open Access
Joint transcriptomics and metabolomics unveil the protective mechanism of tamarind seed polysaccharide against antibiotic-induced intestinal barrier damage
Yinan Chen, Xujiao Li, Xianbao Sun, et al.
International Journal of Biological Macromolecules (2025), pp. 140999-140999
Closed Access
Yinan Chen, Xujiao Li, Xianbao Sun, et al.
International Journal of Biological Macromolecules (2025), pp. 140999-140999
Closed Access
Orally Administrated Inulin-Modified Nanozymes for CT-Guided IBD Theranostics
Xinwen Li, Lin Cao, Jian-Min Li, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2119-2131
Open Access
Xinwen Li, Lin Cao, Jian-Min Li, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2119-2131
Open Access
Treatment sequencing in inflammatory bowel disease : towards clinical precision medicine
Léa Sequier, Bénédicte Caron, Sailish Honap, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101994-101994
Closed Access
Léa Sequier, Bénédicte Caron, Sailish Honap, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101994-101994
Closed Access
Geniposide ameliorates dextran sulfate sodium-induced ulcerative colitis via KEAP1-Nrf2 signaling pathway
Xiaoju Zhuge, Xiaosheng Jin, Tingting Ji, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116626-116626
Closed Access | Times Cited: 13
Xiaoju Zhuge, Xiaosheng Jin, Tingting Ji, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116626-116626
Closed Access | Times Cited: 13
Precision medicine and drug optimization in adult inflammatory bowel disease patients
Sophie Vieujean, Édouard Louis
Therapeutic Advances in Gastroenterology (2023) Vol. 16
Open Access | Times Cited: 12
Sophie Vieujean, Édouard Louis
Therapeutic Advances in Gastroenterology (2023) Vol. 16
Open Access | Times Cited: 12
